These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 3426824

  • 1. [Initial experience with using phosphocreatine in patients in the early (up to 6 hours) period of myocardial infarction].
    Samarenko MB, Afonskaia NI, Dvoskina IS, Ruda MIa.
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):75-81. PubMed ID: 3426824
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic possibilities of using phosphocreatine in complicated myocardial infarct].
    Golikov AP, Riabinin VA, Pavlov VA, Avilova OA, Saks VA.
    Ter Arkh; 1987; 59(5):50-3. PubMed ID: 3616943
    [Abstract] [Full Text] [Related]

  • 3. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
    Perepech NB, Nedoshivin AO, Kutuzova A'E.
    Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
    [Abstract] [Full Text] [Related]

  • 4. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB, Nedoshivin AO, Kutuzova AE.
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [Abstract] [Full Text] [Related]

  • 5. The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man.
    Adamopoulos S, Kemp GJ, Thompson CH, Arnolda L, Brunotte F, Stratton JR, Radda GK, Rajagopalan B, Kremastinos DT, Coats AJ.
    J Mol Cell Cardiol; 1999 Oct; 31(10):1913-26. PubMed ID: 10525428
    [Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic effects of growth hormone--in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology.
    Råmunddal T, Gizurarson S, Lorentzon M, Omerovic E.
    J Electrocardiol; 2008 Oct; 41(2):144-51. PubMed ID: 18328337
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM, Alekhina OD, Zemskov VM, Zemskov MA, Zoloedov VI.
    Ter Arkh; 2008 Oct; 80(1):32-7. PubMed ID: 18326224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Neoton and thrombolytic therapy of myocardial infarction].
    Perepech NB, Nedoshivin AO, Nesterova IV.
    Ter Arkh; 2001 Oct; 73(9):50-5. PubMed ID: 11642083
    [Abstract] [Full Text] [Related]

  • 10. [One-year observation of QT and corrected QT interval dispersion in patients with myocardial infarction].
    Kobusiak-Prokopowicz M, Jołda-Mydłowska B, Negrusz-Kawecka M.
    Przegl Lek; 2003 Oct; 60(2):85-8. PubMed ID: 12939853
    [Abstract] [Full Text] [Related]

  • 11. Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
    Kleber FX, Reindl I, Wenzel M, Rodewyk P, Beil S, Kosloswki B, Doering W, Sabin GV, Hinzmann S, Winter UJ.
    Herz; 1993 Dec; 18 Suppl 1():424-9. PubMed ID: 8125422
    [Abstract] [Full Text] [Related]

  • 12. Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction.
    Owensby DA, O'Rourke MF.
    Aust N Z J Med; 1985 Dec; 15(6):704-11. PubMed ID: 3914879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction.
    Ruda MYa, Samarenko MB, Afonskaya NI, Saks VA.
    Am Heart J; 1988 Aug; 116(2 Pt 1):393-7. PubMed ID: 2456682
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dynamics of some biochemical indices in myocardial infarction treated with thrombolysis and creatine phosphate.
    Weinbergová O, Zeman K, Komárek J, Kölbel F, Metelka R, Ostranský J.
    Acta Univ Palacki Olomuc Fac Med; 1996 Aug; 140():91-4. PubMed ID: 9431703
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. QT dispersion and early arrhythmic risk during acute myocardial infarction.
    Ciolli A, Di Lorenzo M, Bevilacqua U, Lo Sardo G, Tripi M, Fidati R, Palamara A.
    G Ital Cardiol; 1999 Dec; 29(12):1438-44. PubMed ID: 10687106
    [Abstract] [Full Text] [Related]

  • 20. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Dec; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.